Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy.
Saved in:
| Title: | Programmed Cell Death Protein 1-Interleukin-2 Bispecific Agents for Cancer Therapy. |
|---|---|
| Authors: | Xu C; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China., Yan T; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China., Wen S; Gastroenterology Department, Henan Health Commission Key Laboratory of Gastrointestinal Cancer Prevention and Treatment, Xinxiang, China., Wu C; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China., Chang T; Gastroenterology Department, Henan Health Commission Key Laboratory of Gastrointestinal Cancer Prevention and Treatment, Xinxiang, China. ctminmail@163.com., Kong E; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China. eykong2012@163.com.; The Second Affiliated Hospital of Henan Medical University, Xinxiang, China. eykong2012@163.com., Liu H; Institute of Psychiatry and Neuroscience, Henan Medical University, Xinxiang, China. liuhuicong@xxmu.edu.cn.; The Second Affiliated Hospital of Henan Medical University, Xinxiang, China. liuhuicong@xxmu.edu.cn. |
| Source: | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2026 May; Vol. 40 (3), pp. 459-478. Date of Electronic Publication: 2026 Apr 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
